Search
Close this search box.
Search

UCB, ByteFlies, collaborate in wearable pilot to monitor epileptic seizures

Byteflies, an Belgian-American start-up company that develops wearable health solutions, is partnering with the biopharmaceutical company UCB to monitor difficult to measure seizures experienced by people with epilepsy.

This collaboration with UCB, active in the field of research and development of medicines to support the management of epilepsy, is an important step forward for Byteflies. It builds upon a recent funding round from a group of American and Belgian investors which raised $600,000.

Byteflies has the ambition to become the reference in wearable health solutions. With its toolkit of specialized wearables, and an accompanying data platform, Byteflies is targeting the pharmaceutical industry, start-ups and research groups. Before the end of this year, Byteflies plans to launch its very own wearable health toolkit which builds upon the company’s own wearable technology, can dramatically accelerate clinical trials and research.

Pilot project for difficult to measure seizures

Currently, Byteflies wearables are being used in a monitoring project for UCB. As part of a consortium, which includes UCB, the University of Leuven, the Leuven University Hospital and product developer PiliPili, Byteflies is providing discreet and accurate monitoring of difficult to measure seizures in a test group of patients.

“UCB is collaborating with ByteFlies to evaluate the benefits of measuring patient symptoms and experiences which, in the future, could support individually tailored care approaches” says Erik Janssen, VP, Head of Innovative Solutions, Neurology Patient Value Unit, UCB. “Everything we do at UCB is inspired by patients, and driven by science. In this regard, harnessing technology and innovation are crucial elements in our mission to provide maximum value to those patients who need it the most”.

Funding provides expertise of investors

Byteflies recently raised $600,000 in capital from a group of private investors in the United States and in Belgium. "This funding will not only give us the necessary resources to grow, but also provides us with the expertise of our investors to lead our company towards the next step," explains Hans Danneels, CEO and co-founder of Byteflies.

Headquartered in Belgium, Byteflies sits at the center of pharmaceutical innovation, with a strong Belgian tradition in the field of clinical research. Its second office, located in Silicon Valley, operates in the heart of digital innovation.

Whixx

ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Balancing regulatory compliance with seamless adoption, healthcare navigates the integration of AI solutions.
A guide to implementing AI in healthcare amid the EU AI Act
AmyWebb-Stephen-Olker
Futurist Amy Webb claims that wearables will evolve into "connectables"
Digital health solutions empower patients to better manage their health and integrate care into their daily lives.
How to improve Digital Patient Engagement to streamline workflows
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin, sulfonylureas, or other medications that can rapidly lower blood glucose.
Smartwatches measuring glucose level: Harmful but easy to buy fake innovations
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
MMC pioneers wireless monitoring for premature infants with the innovative Bambi Belt, revolutionizing care with improved comfort and mobility.
Wireless Monitoring of Vital Signs in Premature Infants at Máxima MC
Follow us